87 filings
8-K
MYO
Myomo Inc
28 Mar 24
Myomo Appoints Heather Getz to its Board of Directors
4:15pm
8-K
MYO
Myomo Inc
7 Mar 24
Myomo Reports Fourth Quarter and Full Year 2023 Financial Results
4:10pm
8-K
MYO
Myomo Inc
1 Mar 24
Other Events
8:15am
8-K
MYO
Myomo Inc
22 Feb 24
Departure of Directors or Certain Officers
4:54pm
8-K
MYO
Myomo Inc
17 Jan 24
Myomo Reports Preliminary Fourth Quarter Revenue and Backlog
4:20pm
8-K
pv4eqwlp126g37ig4mfm
19 Dec 23
Departure of Directors or Certain Officers
4:30pm
8-K
yeq tp808mo802zn
7 Nov 23
Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations
4:15pm
8-K
zlx35ohs
6 Nov 23
CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro® for Review at the Upcoming HCPCS Public Meeting
8:45am
8-K
xp8ltyifow93fcfx5t9
2 Nov 23
Myomo Announces that CMS has Classified the MyoPro Orthosis Under the Brace Benefit Category
4:05pm
8-K
k0hd0ldd qh3
28 Aug 23
Entry into a Material Definitive Agreement
5:23pm
8-K
0fhodr6w
24 Aug 23
Myomo Receives Medicare Part B Reimbursement for First MyoPro® Claims
4:06pm
8-K
d9o nynja6
9 Aug 23
Myomo Reports Second Quarter 2023 Financial Results Featuring Year Over Year Growth in Revenue and Operating Metrics
4:11pm
8-K
s3u3d
9 Jun 23
Submission of Matters to a Vote of Security Holders
8:30am
8-K
ji8 t7zjihf
10 May 23
Myomo Reports First Quarter 2023 Financial Results Featuring 20% Year Over Year Increase in Product Revenue
4:17pm
8-K
nm75vr jj16s
10 Apr 23
Myomo Receives Technology License Fee Payment from China Joint Venture Company
8:46am
8-K
raf 80e5h
13 Mar 23
Myomo Reports Fourth Quarter and Full Year 2022 Financial Results
8:40am
8-K
m2le3522cp121
30 Jan 23
Myomo Appoints Yitzchak Jacobovitz to its Board of Directors
4:16pm
8-K
e2tnlfjnuaag6
13 Jan 23
Entry into a Material Definitive Agreement
5:17pm
8-K
nff132 9n82cko
10 Jan 23
Myomo Announces Initiative to Reduce Cash Burn
4:35pm
8-K
4w38bygj
7 Dec 22
Other Events
4:16pm